QuartataWeb
Home  |   About  |   Theory  |   Tutorials  |   FAQ  |   Bahar Lab  |   Statistics

 

Network of interactions between drugs (red spheres) and targets (blue spheres) is displayed above.
The red lines are used for the predicted interactions and the thickness of edges indicate the confidence score of predictions.


39 known interactions (drugs) of input target (TNF): Tumor necrosis factor
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image
1 Investigational SmallMoleculeDrug DB05412 Talmapimod Thumb
2 Approved;
Investigational;
Vet approved
SmallMoleculeDrug DB01407 Clenbuterol Thumb
3 Approved BiotechDrug DB10772 Foreskin keratinocyte (neonatal) Thumb
4 Approved;
Vet approved
SmallMoleculeDrug DB00668 Epinephrine Thumb
5 Investigational SmallMoleculeDrug DB05017 YSIL6 Thumb
6 Approved;
Investigational
SmallMoleculeDrug DB01296 Glucosamine Thumb
7 Investigational SmallMoleculeDrug DB05513 Atiprimod Thumb
8 Investigational SmallMoleculeDrug DB05207 SD118 Thumb
9 Investigational SmallMoleculeDrug DB05303 OMS-103HP Thumb
10 Investigational SmallMoleculeDrug DB05869 Ethyl pyruvate Thumb
11 Approved SmallMoleculeDrug DB01427 Amrinone Thumb
12 Approved;
Experimental
SmallMoleculeDrug DB13751 Glycyrrhizic acid Thumb
13 Approved SmallMoleculeDrug DB08910 Pomalidomide Thumb
14 Investigational BiotechDrug DB05218 PN0621 Thumb
15 Approved;
Investigational;
Vet approved
SmallMoleculeDrug DB00608 Chloroquine Thumb
16 Approved SmallMoleculeDrug DB00852 Pseudoephedrine Thumb
17 Approved;
Investigational
SmallMoleculeDrug DB09221 Polaprezinc Thumb
18 Approved;
Investigational
BiotechDrug DB00005 Etanercept Thumb
19 Investigational SmallMoleculeDrug DB05470 VX-702 Thumb
20 Approved;
Investigational
SmallMoleculeDrug DB11967 Binimetinib Thumb
21 Approved BiotechDrug DB06674 Golimumab Thumb
22 Investigational SmallMoleculeDrug DB05968 PR-104 Thumb
23 Investigational SmallMoleculeDrug DB12140 Dilmapimod Thumb
24 Approved BiotechDrug DB00051 Adalimumab Thumb
25 Approved;
Investigational;
Withdrawn
SmallMoleculeDrug DB01041 Thalidomide Thumb
26 Investigational BiotechDrug DB06495 Onercept Thumb
27 Approved BiotechDrug DB10770 Foreskin fibroblast (neonatal) Thumb
28 Investigational SmallMoleculeDrug DB06444 Dexanabinol Thumb
29 Investigational SmallMoleculeDrug DB05744 CRx-139 Thumb
30 Investigational BiotechDrug DB05879 AME-527 Thumb
31 Investigational SmallMoleculeDrug DB05992 Plinabulin Thumb
32 Approved;
Investigational
SmallMoleculeDrug DB01411 Pranlukast Thumb
33 Approved;
Investigational
SmallMoleculeDrug DB05676 Apremilast Thumb
34 Approved;
Investigational
SmallMoleculeDrug DB02325 Isopropyl Alcohol Thumb
35 Investigational SmallMoleculeDrug DB05767 Andrographolide Thumb
36 Approved BiotechDrug DB00065 Infliximab Thumb
37 Investigational BiotechDrug DB05758 CYT007-TNFQb Thumb
38 Investigational BiotechDrug DB04956 Afelimomab Thumb
39 Approved BiotechDrug DB08904 Certolizumab pegol Thumb


20 predicted interactions (drugs) of input target (TNF): Tumor necrosis factor
No. Group Type Drug ID Drug Name SMILES
⇨ TargetHunter
Image Confidence score
1 Experimental SmallMoleculeDrug DB08342 S-PALMITOYL-L-CYSTEINE Thumb 48.5%
2 Approved;
Investigational
BiotechDrug DB09036 Siltuximab Thumb 42.9%
3 Approved;
Investigational;
Nutraceutical
SmallMoleculeDrug DB01404 Ginseng Thumb 42.4%
4 Approved;
Investigational
BiotechDrug DB00072 Trastuzumab Thumb 38.2%
5 Approved;
Investigational
SmallMoleculeDrug DB01017 Minocycline Thumb 37.6%
6 Approved;
Investigational
BiotechDrug DB00074 Basiliximab Thumb 36.9%
7 Approved;
Investigational
SmallMoleculeDrug DB01593 Zinc Thumb 36.6%
8 Approved BiotechDrug DB00002 Cetuximab Thumb 35.3%
9 Investigational SmallMoleculeDrug DB06083 Tapinarof Thumb 34.7%
10 Approved;
Investigational;
Vet approved
SmallMoleculeDrug DB01392 Yohimbine Thumb 34.6%
11 Approved;
Investigational
BiotechDrug DB06168 Canakinumab Thumb 31.1%
12 Approved;
Investigational
BiotechDrug DB00075 Muromonab Thumb 30.6%
13 Experimental;
Investigational
SmallMoleculeDrug DB03496 Alvocidib Thumb 30.0%
14 Approved;
Investigational;
Withdrawn
BiotechDrug DB06607 Catumaxomab Thumb 28.5%
15 Experimental SmallMoleculeDrug DB07636 5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE Thumb 27.7%
16 Approved SmallMoleculeDrug DB00502 Haloperidol Thumb 27.3%
17 Investigational BiotechDrug DB05110 VIR201 Thumb 26.5%
18 Experimental SmallMoleculeDrug DB08453 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE Thumb 26.2%
19 Approved;
Investigational
BiotechDrug DB00112 Bevacizumab Thumb 26.2%
20 Approved;
Investigational
BiotechDrug DB00028 Immune Globulin Human Thumb 26.1%



  logl

Reference:  Hongchun Li, Fen Pei, D. Lansing Taylor and Ivet Bahar. (2020) QuartataWeb: Integrated Chemical–Protein-Pathway Mapping for Polypharmacology and Chemogenomics. Bioinformatics 36(12), 3935–3937.

Contact:

The QuartataWeb server is maintained by the Bahar Lab at the Department of Computational & Systems Biology at the University of Pittsburgh, School of Medicine, and sponsored by the NIH awards P41 GM103712 and P01 DK096990; and by the Li Lab at Research Center for Computer-Aided Drug Discovery at Shenzhen Institutes of Advanced Technology, CAS.

For questions and comments please contact Hongchun Li.